References from Dendritic cell-based immunotherapy of hormone refractory prostate carcinoma (HRPCa) – a pilot trial. Local targets link to admitted publications; unresolved targets remain external evidence.
No reference evidence is available for this admitted work.
References for Dendritic cell-based immunotherapy of hormone refractory prostate carcinoma (HRPCa) – a pilot trial | ResearchHub - ResearchHub
